Confidential Oura IPO Filing Confirms Market Ambitions
Oura Health Oy has confidentially submitted paperwork for a US initial public offering, formally confirming earlier reporting that an Oura IPO filing was imminent. The smart ring maker disclosed that it had filed documentation with the US Securities and Exchange Commission, but has yet to determine the number of shares or price range for the proposed sale. The listing is expected to follow the SEC’s review and will be subject to market conditions, with sources indicating the company aims to go public later this year. Oura is working with a heavyweight syndicate that includes Goldman Sachs, Morgan Stanley, JPMorgan, Allen & Co. and Jefferies, signaling serious capital markets ambitions. The move places Oura alongside a broader resurgence in technology flotations, with high-profile names such as SpaceX and OpenAI also advancing IPO plans and reinforcing investor appetite for growth-focused tech issuers.
Soaring Valuation and Membership Signal Investor Confidence
Oura’s IPO valuation backdrop is striking: the company was valued at about USD 11 billion (approx. RM50.6 billion) after completing a USD 900 million (approx. RM4.14 billion) Series E financing round in October 2025. That funding built on an earlier report of an USD 875 million (approx. RM4.03 billion) raise that helped cement Oura’s status as a leading player in health tracking wearables. The business has reported strong top-line momentum, generating more than USD 500 million (approx. RM2.3 billion) in revenue in 2024 and projecting to double that figure in 2025, with internal expectations of USD 1.5 billion (approx. RM6.91 billion) in revenue by 2026. In May 2026, Oura also said it was on course to surpass five million paid members this quarter, a fourfold increase in two years. Together, these metrics underscore why investors view the smart ring maker as a high-growth platform in wearable wellness technology.
Smart Rings Surge as Alternative to Watches
The timing of the Oura IPO filing coincides with a surge in demand for smart rings as consumers increasingly seek less obtrusive health tracking wearables. Oura has capitalised on this shift by offering a compact ring that tracks sleep, fitness and cardiovascular metrics and syncs with a companion app on both iOS and Android devices. Unlike bulky smartwatches, rings appeal to users who want 24/7 monitoring without a prominent device on the wrist. Oura reported cumulative sales of 5.5 million rings by September, more than doubling from 2.5 million in mid-2024, illustrating the rapid expansion of the category. Although fitness rings still represent a small share of the broader wearables market, their growth trajectory is steep, and the company’s subscription-based membership model deepens engagement. This combination of hardware adoption and recurring software revenue is a key part of the growth story Oura will likely highlight to IPO investors.
Partnerships Blur the Line Between Wellness and Medtech
Beyond consumer fitness, Oura is steadily moving closer to the medical technology ecosystem, a shift that may further bolster its IPO narrative. The Oura Ring is formally positioned as a wellness product, yet the company has forged alliances with medtech and femtech players to enrich its health data. Dexcom invested USD 75 million (approx. RM345 million) in Oura in late 2024, with the two companies working to integrate continuous glucose monitoring data with Oura’s sleep, stress and cardiovascular insights. This could give users a more nuanced view of how lifestyle factors influence glucose variability. Meanwhile, a partnership with hormone-testing specialist Mira allows Oura users to access lab-grade fertility and hormone data. These collaborations suggest a future in which smart rings become hubs for multimodal biometrics, strengthening Oura’s positioning at the intersection of consumer wearables, digital health, and clinical-grade data platforms.
Facing Down Tech Giants in the Wearables Battle
Oura’s push toward the public markets comes as competition intensifies in health tracking wearables. The company has already forced established players like Apple and Samsung to respond to the smart ring trend. Samsung introduced its own ring two years ago, while Apple is exploring a broader lineup of AI-powered wearable devices. For Oura, which operates out of main offices in San Francisco and Finland and was founded in 2013, the challenge is to defend and extend its early-mover advantage as big tech enters the category. The IPO could provide fresh capital for research, marketing, and international expansion at a time when brand recognition and ecosystem depth are becoming critical differentiators. Investor enthusiasm for the offering will hinge on whether Oura can maintain rapid user and revenue growth while withstanding pressure from larger rivals with integrated hardware, software, and services platforms.